Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cochlear ( (AU:COH) ) has shared an update.
AustralianSuper Pty Ltd has disclosed that it has ceased to be a substantial shareholder in Cochlear Ltd, following a change in its relevant interest in the company’s voting securities. According to the notice, the change was effected through a sell transaction executed via JPMorgan Nominees Australia Ltd on 24 April 2026, reducing AustralianSuper’s holding below the substantial shareholder threshold and potentially altering Cochlear’s institutional investor base and voting dynamics.
The transaction involved the sale of 730,425 ordinary shares, marking a significant adjustment in AustralianSuper’s exposure to Cochlear. While no change in associations was reported, the move may signal a strategic portfolio rebalancing by one of Australia’s major institutional investors and could be closely watched by the market for any implications for Cochlear’s shareholder structure and governance influence.
The most recent analyst rating on (AU:COH) stock is a Hold with a A$111.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Ltd is a global medical device company specialising in implantable hearing solutions. The company develops and manufactures cochlear implants and related hearing technologies, targeting patients with moderate to profound hearing loss and operating within the broader healthcare and audiology markets.
Average Trading Volume: 408,512
Technical Sentiment Signal: Sell
Current Market Cap: A$6.37B
See more data about COH stock on TipRanks’ Stock Analysis page.